Pricing
Login
Home
Charts
Search
Watchlist
Products

Strides Pharma Science Ltd

STAR
₹967.30-1.21%20 Nov 2026
Reports
Pharma Formulations

Strides Pharma Science Ltd

STAR
₹967.30
-1.21%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹8,917Cr
Close
Close Price
₹967.30
Industry
Industry
Pharma Formulations
PE
Price To Earnings
14.46
PS
Price To Sales
1.71
Revenue
Revenue
₹5,213Cr
Rev Gr TTM
Revenue Growth TTM
11.28%
PAT Gr TTM
PAT Growth TTM
54.33%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,0061,0441,0541,1671,1541,1901,1201,2211,1951,3231,2651,430
Growth YoY
Revenue Growth YoY%
16.35.813.416.814.714.16.24.63.511.213.017.1
Expenses
ExpensesCr
8648398649829439739029899591,0841,0361,179
Operating Profit
Operating ProfitCr
142204190185210218218232236240230251
OPM
OPM%
14.119.618.015.818.218.319.519.019.818.118.217.6
Other Income
Other IncomeCr
-14-57110244-120171043673
Interest Expense
Interest ExpenseCr
707173745250474643424147
Depreciation
DepreciationCr
494847484849495051535657
PBT
PBTCr
92918086114106122153245148200150
Tax
TaxCr
161319142421162237193416
PAT
PATCr
54103,350729086106132208129165134
Growth YoY
PAT Growth YoY%
165.8175.735,886.1148.366.6720.1-96.882.0131.151.056.72.0
NPM
NPM%
5.41.0317.76.27.87.29.410.817.49.813.19.4
EPS
EPS₹
2.40.9159.83.49.68.910.813.821.913.817.014.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,0061,0441,0541,1671,1541,1901,1201,2211,1951,3231,2651,430
Growth YoY
Revenue Growth YoY%
16.35.813.416.814.714.16.24.63.511.213.017.1
Expenses
ExpensesCr
8648398649829439739029899591,0841,0361,179
Operating Profit
Operating ProfitCr
142204190185210218218232236240230251
OPM
OPM%
14.119.618.015.818.218.319.519.019.818.118.217.6
Other Income
Other IncomeCr
-14-57110244-120171043673
Interest Expense
Interest ExpenseCr
707173745250474643424147
Depreciation
DepreciationCr
494847484849495051535657
PBT
PBTCr
92918086114106122153245148200150
Tax
TaxCr
161319142421162237193416
PAT
PATCr
54103,350729086106132208129165134
Growth YoY
PAT Growth YoY%
165.8175.735,886.1148.366.6720.1-96.882.0131.151.056.72.0
NPM
NPM%
5.41.0317.76.27.87.29.410.817.49.813.19.4
EPS
EPS₹
2.40.9159.83.49.68.910.813.821.913.817.014.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,1562,7552,8452,1782,7523,3163,0703,6883,8904,5654,8595,213
Growth
Revenue Growth%
163.9-12.73.3-23.426.320.5-7.420.15.517.46.411.3
Expenses
ExpensesCr
2,6352,2282,4311,9362,2362,6813,0903,2583,3083,7633,9334,257
Operating Profit
Operating ProfitCr
521527414242516635-20430582803925956
OPM
OPM%
16.519.114.611.118.819.1-0.711.715.017.619.018.3
Other Income
Other IncomeCr
741251617-132-3-223-212-203125124177
Interest Expense
Interest ExpenseCr
18018319679156150177261280249179172
Depreciation
DepreciationCr
157126154117174206233243214192202217
PBT
PBTCr
258343806255275-653-286-115487669744
Tax
TaxCr
69636-271132-178-55297894107
PAT
PATCr
189280748943244-474-212-94409575637
Growth
PAT Growth%
19,155.448.2-73.520.2-51.4462.3-294.555.255.6534.140.354.3
NPM
NPM%
6.010.22.64.11.67.3-15.4-5.8-2.49.011.812.2
EPS
EPS₹
5.619.031.515.91.813.1-22.5-9.9-3.4390.560.366.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,1562,7552,8452,1782,7523,3163,0703,6883,8904,5654,8595,213
Growth
Revenue Growth%
163.9-12.73.3-23.426.320.5-7.420.15.517.46.411.3
Expenses
ExpensesCr
2,6352,2282,4311,9362,2362,6813,0903,2583,3083,7633,9334,257
Operating Profit
Operating ProfitCr
521527414242516635-20430582803925956
OPM
OPM%
16.519.114.611.118.819.1-0.711.715.017.619.018.3
Other Income
Other IncomeCr
741251617-132-3-223-212-203125124177
Interest Expense
Interest ExpenseCr
18018319679156150177261280249179172
Depreciation
DepreciationCr
157126154117174206233243214192202217
PBT
PBTCr
258343806255275-653-286-115487669744
Tax
TaxCr
69636-271132-178-55297894107
PAT
PATCr
189280748943244-474-212-94409575637
Growth
PAT Growth%
19,155.448.2-73.520.2-51.4462.3-294.555.255.6534.140.354.3
NPM
NPM%
6.010.22.64.11.67.3-15.4-5.8-2.49.011.812.2
EPS
EPS₹
5.619.031.515.91.813.1-22.5-9.9-3.4390.560.366.9
Sales CAGR
1 Year6%
3 Years10%
5 Years8%
TTM11%
EBITDA CAGR
1 Year15%
3 Years29%
5 Years8%
TTM9%
PAT CAGR
1 Year40%
3 Years-
5 Years19%
TTM54%
Avg. ROCE
1 Year17%
3 Years13%
5 Years6%
TTM17%
CFO / EBITDA
1 Year76%
3 Years90%
5 Years69%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
898990909090909092929292
Reserves
ReservesCr
2,7742,6592,3742,5592,4382,6872,2692,1222,0342,4603,0153,324
Current Liabilities
Current LiabilitiesCr
1,9403,1041,8992,6622,5452,7383,4122,9902,8792,5922,8953,135
Non Current Liabilities
Non Current LiabilitiesCr
2,8132,1192,1912,5161,0121,4631,1811,475889871882883
Total Liabilities
Total LiabilitiesCr
7,6598,1056,7087,9806,1527,0156,9766,6385,8406,0496,9277,489
Current Assets
Current AssetsCr
3,5953,7922,4843,0492,3722,8173,3623,1352,9693,0993,6134,037
Non Current Assets
Non Current AssetsCr
4,0644,3134,2254,9313,7804,1983,6143,3952,8712,9503,3143,452
Total Assets
Total AssetsCr
7,6598,1056,7087,9806,1527,0156,9766,6385,8406,0496,9277,489
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
898990909090909092929292
Reserves
ReservesCr
2,7742,6592,3742,5592,4382,6872,2692,1222,0342,4603,0153,324
Current Liabilities
Current LiabilitiesCr
1,9403,1041,8992,6622,5452,7383,4122,9902,8792,5922,8953,135
Non Current Liabilities
Non Current LiabilitiesCr
2,8132,1192,1912,5161,0121,4631,1811,475889871882883
Total Liabilities
Total LiabilitiesCr
7,6598,1056,7087,9806,1527,0156,9766,6385,8406,0496,9277,489
Current Assets
Current AssetsCr
3,5953,7922,4843,0492,3722,8173,3623,1352,9693,0993,6134,037
Non Current Assets
Non Current AssetsCr
4,0644,3134,2254,9313,7804,1983,6143,3952,8712,9503,3143,452
Total Assets
Total AssetsCr
7,6598,1056,7087,9806,1527,0156,9766,6385,8406,0496,9277,489

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7228818760205481-25844701684703
Investing Cash Flow
Investing Cash FlowCr
-2,228-687583-1481,306-521-119302-150-90-173
Financing Cash Flow
Financing Cash FlowCr
2,949338-1,016194-1,709-16421-214-693-643-453
Net Cash Flow
Net Cash FlowCr
792-60-246106-199-5545133-143-4876
Free Cash Flow
Free Cash FlowCr
75-386-212-256208485-18252790505291
CFO To PAT
CFO To PAT%
38.0103.0251.967.3472.3197.554.4-20.9-743.3167.2122.3
CFO To EBITDA
CFO To EBITDA%
13.854.645.124.839.775.81,282.310.3120.485.375.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7228818760205481-25844701684703
Investing Cash Flow
Investing Cash FlowCr
-2,228-687583-1481,306-521-119302-150-90-173
Financing Cash Flow
Financing Cash FlowCr
2,949338-1,016194-1,709-16421-214-693-643-453
Net Cash Flow
Net Cash FlowCr
792-60-246106-199-5545133-143-4876
Free Cash Flow
Free Cash FlowCr
75-386-212-256208485-18252790505291
CFO To PAT
CFO To PAT%
38.0103.0251.967.3472.3197.554.4-20.9-743.3167.2122.3
CFO To EBITDA
CFO To EBITDA%
13.854.645.124.839.775.81,282.310.3120.485.375.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,7259,8086,0154,2242,8897,5743,1122,5847,1926,1668,6448,917
Price To Earnings
Price To Earnings
90.824.59.113.079.528.21.715.514.5
Price To Sales
Price To Sales
3.43.62.11.91.12.31.00.71.91.41.81.7
Price To Book
Price To Book
3.73.62.41.61.12.71.31.23.42.42.82.6
EV To EBITDA
EV To EBITDA
24.723.719.828.39.215.0-295.911.716.29.811.011.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
43.147.545.842.650.651.540.948.750.350.3
OPM
OPM%
16.519.114.611.118.819.1-0.711.715.017.619.018.3
NPM
NPM%
6.010.22.64.11.67.3-15.4-5.8-2.49.011.812.2
ROCE
ROCE%
6.99.15.62.44.58.6-8.8-0.53.616.617.417.4
ROE
ROE%
6.610.23.03.41.78.8-20.1-9.6-4.416.018.518.6
ROA
ROA%
2.53.51.11.10.73.5-6.8-3.2-1.66.88.38.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,7259,8086,0154,2242,8897,5743,1122,5847,1926,1668,6448,917
Price To Earnings
Price To Earnings
90.824.59.113.079.528.21.715.514.5
Price To Sales
Price To Sales
3.43.62.11.91.12.31.00.71.91.41.81.7
Price To Book
Price To Book
3.73.62.41.61.12.71.31.23.42.42.82.6
EV To EBITDA
EV To EBITDA
24.723.719.828.39.215.0-295.911.716.29.811.011.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
43.147.545.842.650.651.540.948.750.350.3
OPM
OPM%
16.519.114.611.118.819.1-0.711.715.017.619.018.3
NPM
NPM%
6.010.22.64.11.67.3-15.4-5.8-2.49.011.812.2
ROCE
ROCE%
6.99.15.62.44.58.6-8.8-0.53.616.617.417.4
ROE
ROE%
6.610.23.03.41.78.8-20.1-9.6-4.416.018.518.6
ROA
ROA%
2.53.51.11.10.73.5-6.8-3.2-1.66.88.38.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr13,84213,19610,9588,9177,6126,8146,147
Close PriceClose₹2,263.20291.15696.20967.30269.40640.55377.55
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE66.8623.5629.3014.4642.0919.62
Price To SalesPS8.883.892.271.71836.516.342.69
RevenueRevenueCr1,5593,3924,8265,21391,0742,289
Revenue Growth TTMRev Gr TTM%20.0%24.2%17.5%11.3%55.0%24.9%10.2%
PAT Growth TTMPAT Gr TTM%18.3%60.2%12.8%54.3%-80.3%44.3%39.0%
Market CapitalizationMkt CapCr13,84213,19610,9588,9177,6126,8146,147
Close PriceClose₹2,263.20291.15696.20967.30269.40640.55377.55
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE66.8623.5629.3014.4642.0919.62
Price To SalesPS8.883.892.271.71836.516.342.69
RevenueRevenueCr1,5593,3924,8265,21391,0742,289
Revenue Growth TTMRev Gr TTM%20.0%24.2%17.5%11.3%55.0%24.9%10.2%
PAT Growth TTMPAT Gr TTM%18.3%60.2%12.8%54.3%-80.3%44.3%39.0%
Annual Reports
Quarterly Reports
FY
Annual Reports
Quarterly Reports
Interviews